8-KThe WireRoutine
Shareholder Vote
Filed Jun 17, 2026 · 12d ago · Accession 0001193125-26-274093
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- 8-K
- Filing date
- Jun 17, 2026
- Report date
- Apr 28, 2026
- Document
- dmra-20260428.htm
- Size
- 208 KB